Biotech Nektar to Announce Financial Results for the Second Quarter on Thursday, August 7, 2025, After Close of U.S.-Based Financial Markets August 1, 2025
Biotech Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson’s Disease August 1, 2025
Biotech OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure July 31, 2025
Biotech THR-β Agonist Market on the Rise: Insights and Projections Upto 2034 | DelveInsight July 31, 2025
Biotech Triple-Negative Breast Cancer Market Gearing Up for Impressive Growth at a CAGR of 4.7% During the Forecast Period (2025-2034) | DelveInsight July 30, 2025
Biotech Kinvard Bio Secures Follow-on CARB-X Funding to Accelerate Development of Next-Generation Antibiotics July 29, 2025
Biotech WuXi Biologics Singapore CRDMO Hub Advances with the Launch of Modular Drug Product Facility Fabrication July 29, 2025
Biotech Elpis Biopharmaceuticals Signs Memorandum of Understanding with National Cancer Centre Singapore to Conduct Translational Cell Therapy Research in Singapore July 28, 2025
Biotech Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025 July 28, 2025